{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:59:12Z","timestamp":1743011952653},"reference-count":36,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2018.5939","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T10:04:35Z","timestamp":1520589875000},"source":"Crossref","is-referenced-by-count":2,"title":["ASXL1 mutations in Chinese patients with essential thrombocythemia"],"prefix":"10.3892","author":[{"given":"Yan\u2011Bo","family":"Nie","sequence":"first","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"He","sequence":"additional","affiliation":[{"name":"Stego Tech LLC, Audubon, PA 19403, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man\u2011Kai","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology and Hospital of Blood Diseases Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 300000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu\u2011Ling","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San\u2011Yun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting\u2011Ting","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Fifth Hospital of Wuhan, Wuhan, Hubei 430050, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue\u2011Lan","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"key20200713144823_b1-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"57036","DOI":"10.18632\/oncotarget.10958","article-title":"Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia","volume":"7","author":"Kang","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713144823_b2-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1182\/blood-2008-09-176818","article-title":"Response criteria for essential thrombocythemia and polycythemia vera: Result of a European LeukemiaNet consensus conference","volume":"113","author":"Barosi","year":"2009","journal-title":"Blood"},{"key":"key20200713144823_b3-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.blre.2016.06.001","article-title":"The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances","volume":"30","author":"Barbui","year":"2016","journal-title":"Blood Rev"},{"key":"key20200713144823_b4-etm-0-0-5939","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026526","article-title":"The Role of Additional Sex Combs-Like Proteins in Cancer","volume":"6","author":"Micol","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20200713144823_b5-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2013.281","article-title":"Functional and cancer genomics of ASXL family members","volume":"109","author":"Katoh","year":"2013","journal-title":"Br J Cancer"},{"key":"key20200713144823_b6-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1mutations promot myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell"},{"key":"key20200713144823_b7-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.3324\/haematol.2014.120931","article-title":"Mutations of ASXL1 and TET2 in aplastic anemia","volume":"100","author":"Huang","year":"2015","journal-title":"Haematologica"},{"key":"key20200713144823_b8-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200713144823_b9-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"key20200713144823_b10-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","article-title":"Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases","volume":"5","author":"Gelsi-Boyer","year":"2012","journal-title":"J Hematol Oncol"},{"key":"key20200713144823_b11-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/ijms17040440","article-title":"Molecular and cellular mechanisms of myelodysplastic syndrome: Implications on targeted therapy","volume":"17","author":"Gill","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20200713144823_b12-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2013.119","article-title":"Mutations and prognosis in primary myelofibrosis","volume":"27","author":"Vannucchi","year":"2013","journal-title":"Leukemia"},{"key":"key20200713144823_b13-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1756-8722-6-68","article-title":"Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: Clonal evolution and hierarchy revealed by next-generation sequencing","volume":"6","author":"Ferrer-Marin","year":"2013","journal-title":"J Hematol Oncol"},{"key":"key20200713144823_b14-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Shih","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"key20200713144823_b15-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/PPO.0000000000000013","article-title":"Genetics of myeloproliferative neoplasms","volume":"20","author":"Viny","year":"2014","journal-title":"Cancer J"},{"key":"key20200713144823_b16-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12185-012-1235-2","article-title":"Genetic and epigenetic alterations of myeloproliferative disorders","volume":"97","author":"Milosevic","year":"2013","journal-title":"Int J Hematol"},{"key":"key20200713144823_b17-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3324\/haematol.2014.118299","article-title":"Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations","volume":"100","author":"Al Assaf","year":"2015","journal-title":"Haematologica"},{"key":"key20200713144823_b18-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12185-017-2246-9","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"105","author":"Imai","year":"2017","journal-title":"Int J Hematol"},{"key":"key20200713144823_b19-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/jclinpath-2016-203899","article-title":"The Calreticulin gene and myeloproliferative neoplasms","volume":"69","author":"Clinton","year":"2016","journal-title":"J Clin Pathol"},{"key":"key20200713144823_b20-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/10428190801895360","article-title":"JAK and MPL mutations in myeloid malignancies","volume":"49","author":"Tefferi","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20200713144823_b21-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3892\/etm.2017.4077","article-title":"Significance of combined detection of JAK2V617F, MPL and CALR gene mutations in patients with essential thrombocythemia","volume":"13","author":"Ji","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20200713144823_b22-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10245332.2016.1252003","article-title":"JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia","volume":"22","author":"Wang","year":"2017","journal-title":"Hematology"},{"key":"key20200713144823_b23-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7150\/ijms.10539","article-title":"Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive polycythemia vera (PV) and essential thrombocythemia (ET)","volume":"13","author":"Zhao","year":"2016","journal-title":"Int J Med Sci"},{"key":"key20200713144823_b24-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"key":"key20200713144823_b25-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3324\/haematol.2014.114157","article-title":"ASXL1 mutations in younger adult patients with acute myeloid leukemia: A study by the German-Austrian Acute Myeloid Leukemia Study Group","volume":"100","author":"Paschka","year":"2015","journal-title":"Haematologica"},{"key":"key20200713144823_b26-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.hoc.2012.07.009","article-title":"Clinical predictors of outcome in MPN","volume":"26","author":"Passamonti","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20200713144823_b27-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","article-title":"Survival and disease progression in essential thrombo-cythemia are significantly influenced by accurate morphologic diagnosis: An international study","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200713144823_b28-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5306\/wjco.v7.i4.324","article-title":"Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia","volume":"7","author":"Shrestha","year":"2016","journal-title":"World J Clin Oncol"},{"key":"key20200713144823_b29-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.leukres.2016.01.015","article-title":"Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia","volume":"42","author":"Suleiman","year":"2016","journal-title":"Leuk Res"},{"key":"key20200713144823_b30-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3109\/10428194.2014.939963","article-title":"CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia","volume":"56","author":"Shen","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key20200713144823_b31-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/leu.2010.144","article-title":"The most commonly reported variant in ASXL1 (c.1934dupG;p. Gly646TrpfsX12) is not a somatic alteration","volume":"24","author":"Abdel-Wahab","year":"2010","journal-title":"Leukemia"},{"key":"key20200713144823_b32-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3324\/haematol.2011.045591","article-title":"Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: Analysis of molecular genetics and clinical phenotypes","volume":"96","author":"Stein","year":"2011","journal-title":"Haematologica"},{"key":"key20200713144823_b33-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1182\/blood-2016-05-643346","article-title":"How I treat essential thrombocythemia","volume":"128","author":"Rumi","year":"2016","journal-title":"Blood"},{"key":"key20200713144823_b34-etm-0-0-5939","article-title":"Recent advances in understanding myelofibrosis and essential thrombocythemia","author":"Vainchenker","year":"2016","journal-title":"F1000Res 5: pii: F1000 Faculty Rev-700"},{"key":"key20200713144823_b35-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MOH.0000000000000216","article-title":"Contemporary approach to essential thrombocythemia and polycythemia vera","volume":"23","author":"Aruch","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"key20200713144823_b36-etm-0-0-5939","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ajh.24288","article-title":"Myeloproliferative neoplasms: Morphology and clinical practice","volume":"91","author":"Barbui","year":"2016","journal-title":"Am J Hematol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T13:49:31Z","timestamp":1594648171000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2018.5939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3892\/etm.2018.5939","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}